谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Pamrevlumab Plus Nab-Paclitaxel/gemcitabine (pam + GA) As First- and Second-Line Therapy in Metastatic Pancreatic Cancer (mpdac): Results from Precision Promise (prp) Bayesian Platform Trial.

Vincent J. Picozzi,Anna M. Varghese,Paul Eliezer Oberstein,Manuel Hidalgo,Brian M. Wolpin,Kian-Huat Lim,Anna McGlothlin, Todd Graves,Michelle A. Detry,Mark Fitzgerald, Anna Bosse,Cassadie Moravek, Samantha Pedersen, Anna Berkenblit, Jian Chen,Ewa Carrier, Deyaa R Adib,Donald A. Berry, Diane M. Simeone,Andrew H. Ko

Journal of Clinical Oncology（2025）

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要